Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| RED ROBIN GOURMET BURGERS INCRRGB · Entity 6468 | Director | May 19, 2022 | May 23, 2022 |
| STARBUCKS CORPSBUX · Entity 2886 | evp, Partner Resources | December 15, 2010 | December 17, 2010 |
| Zumiez IncZUMZ · Entity 5948 | Director | February 16, 2022 | February 17, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
RED ROBIN GOURMET BURGERS INC
Report date May 19, 2022 · Filed May 23, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 29,675 |
Reported balance
After 2022-05-19 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-05-19 · Grant · Acquired 9,632 · Balance 29,675 F1: Represents a grant of restricted stock units under the issuer's 2017 Performance Incentive Plan, as amended. Each restricted stock unit represents the contingent right to receive, upon vesting of the unit, one share of the issuer's common stock. The units are scheduled to vest on the earlier of the first anniversary of the date of grant or the next annual meeting of stockholders. F2: Includes 9,632 shares subject to vesting and forfeiture restrictions. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of restricted stock units under the issuer's 2017 Performance Incentive Plan, as amended. Each restricted stock unit represents the contingent right to receive, upon vesting of the unit, one share of the issuer's common stock. The units are scheduled to vest on the earlier of the first anniversary of the date of grant or the next annual meeting of stockholders.
F2: Includes 9,632 shares subject to vesting and forfeiture restrictions.
STARBUCKS CORP
Report date December 15, 2010 · Filed December 17, 2010
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 30,814 |
Reported balance
After 2010-12-15 transaction · row 1
1 source rowRow 1 · 2010-12-15 · Tax withholding · Disposed 2,182 · Balance 30,814 F1: Shares withheld by the issuer to satisfy tax withholding obligations upon vesting of restricted stock units; not an open market transaction. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld by the issuer to satisfy tax withholding obligations upon vesting of restricted stock units; not an open market transaction.
Zumiez Inc
Report date February 16, 2022 · Filed February 17, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,087 |
Reported balance
After 2022-02-16 transaction · row 1
1 source rowRow 1 · 2022-02-16 · Sale · Disposed 2,000 · Balance 5,087 F1: The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan previously adopted by the reporting person in December 2021. F2: Shares sold at a weighted average price. |
Filing footnotes · ownership attribution and instrument terms
F1: The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan previously adopted by the reporting person in December 2021.
F2: Shares sold at a weighted average price.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
1Life Healthcare Inc
Report date February 22, 2023 · Filed February 24, 2023
Section 16 reporting ended · disclosed 2023-02-24. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2023-02-22 transaction · row 1
1 source rowRow 1 · 2023-02-22 · Disposition to issuer · Disposed 4,534 · Balance 0 F1: Reflects disposition of Issuer common stock with the consummation of the transactions contemplated by the Agreement and Plan of Merger (the "Merger Agreement"), dated as of July 20, 2022, by and among Issuer, Amazon.com, Inc. ("Parent") and Negroni Merger Sub, Inc., a wholly owned subsidiary of Parent ("Merger Sub"), including the consummation of the merger (the "Merger") between Issuer and Merger Sub on February 22, 2023. Pursuant to the Merger Agreement, as of the effective time of the Merger (the "Effective Time"), each share of Issuer common stock, par value $0.001 per share ("Shares") issued and outstanding immediately prior to the Effective Time was converted automatically into the right to receive $18.00 in cash, without interest (the "Merger Consideration"). |
| Stock Options (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.47 · Expires 2029-09-18 | Direct | 0 |
Reported balance
After 2023-02-22 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-02-22 · Disposition to issuer · Disposed 13,617 · Balance 0 F2: Pursuant to the Merger Agreement, at the Effective Time, each outstanding option ("Option") to purchase Shares granted under any of the Issuer's 2007 Equity Incentive Plan, 2017 Equity Incentive Plan, 2020 Equity Incentive Plan and the Iora Third Amended and Restated 2011 Equity Incentive Plan (collective, the "Issuer Stock Plans") or portion thereof that was vested or became vested as of the Effective Time, and had an exercise price per Share that is less than the Merger Consideration, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the amount by which the Merger Consideration exceeds the applicable exercise price per Share of such Option and (ii) the aggregate number of Shares issuable upon exercise of such Option or portion thereof, subject to any required withholding of taxes. F3: The shares subject to the option are fully vested and immediately exercisable. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.47 · Expires 2029-09-18 | Direct | 0 |
Reported balance
After 2023-02-22 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-02-22 · Disposition to issuer · Disposed 10,462 · Balance 0 F2: Pursuant to the Merger Agreement, at the Effective Time, each outstanding option ("Option") to purchase Shares granted under any of the Issuer's 2007 Equity Incentive Plan, 2017 Equity Incentive Plan, 2020 Equity Incentive Plan and the Iora Third Amended and Restated 2011 Equity Incentive Plan (collective, the "Issuer Stock Plans") or portion thereof that was vested or became vested as of the Effective Time, and had an exercise price per Share that is less than the Merger Consideration, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the amount by which the Merger Consideration exceeds the applicable exercise price per Share of such Option and (ii) the aggregate number of Shares issuable upon exercise of such Option or portion thereof, subject to any required withholding of taxes. F4: The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the first anniversary of the vesting commencement date; and 1/48th of the shares subject to the option vest monthly thereafter over the following three years, subject to reporting person's continuous service as of each such date. At the Effective Time, any unvested shares subject to the option was accelerated in full. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $29.00 · Expires 2030-05-13 | Direct | 0 |
Reported balance
After 2023-02-22 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2023-02-22 · Disposition to issuer · Disposed 5,294 · Balance 0 F5: Pursuant to the Merger Agreement, at the Effective Time, each Option, whether vested or unvested, that has an exercise price per Share that is greater than the Merger Consideration was canceled without the payment of consideration. F3: The shares subject to the option are fully vested and immediately exercisable. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2023-02-22 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2023-02-22 · Disposition to issuer · Disposed 20,728 · Balance 0 F6: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock. RSUs convert into the issuer's common stock on a one-for-one basis. F7: The RSUs vest on the earlier of (i) the date of the issuer's next annual meeting of stockholders (or the date immediately prior to the next annual meeting of stockholders if the reporting person's service as a director ends at such meeting due to the director's failure to be re-elected or the director not standing for re-election); or (ii) the one-year anniversary measured from the date of grant. At the Effective Time, each outstanding RSU that was unvested was accelerated in full and was automatically converted in to the right to receive the Merger Consideration. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects disposition of Issuer common stock with the consummation of the transactions contemplated by the Agreement and Plan of Merger (the "Merger Agreement"), dated as of July 20, 2022, by and among Issuer, Amazon.com, Inc. ("Parent") and Negroni Merger Sub, Inc., a wholly owned subsidiary of Parent ("Merger Sub"), including the consummation of the merger (the "Merger") between Issuer and Merger Sub on February 22, 2023. Pursuant to the Merger Agreement, as of the effective time of the Merger (the "Effective Time"), each share of Issuer common stock, par value $0.001 per share ("Shares") issued and outstanding immediately prior to the Effective Time was converted automatically into the right to receive $18.00 in cash, without interest (the "Merger Consideration").
F2: Pursuant to the Merger Agreement, at the Effective Time, each outstanding option ("Option") to purchase Shares granted under any of the Issuer's 2007 Equity Incentive Plan, 2017 Equity Incentive Plan, 2020 Equity Incentive Plan and the Iora Third Amended and Restated 2011 Equity Incentive Plan (collective, the "Issuer Stock Plans") or portion thereof that was vested or became vested as of the Effective Time, and had an exercise price per Share that is less than the Merger Consideration, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the amount by which the Merger Consideration exceeds the applicable exercise price per Share of such Option and (ii) the aggregate number of Shares issuable upon exercise of such Option or portion thereof, subject to any required withholding of taxes.
F3: The shares subject to the option are fully vested and immediately exercisable.
F4: The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the first anniversary of the vesting commencement date; and 1/48th of the shares subject to the option vest monthly thereafter over the following three years, subject to reporting person's continuous service as of each such date. At the Effective Time, any unvested shares subject to the option was accelerated in full.
F5: Pursuant to the Merger Agreement, at the Effective Time, each Option, whether vested or unvested, that has an exercise price per Share that is greater than the Merger Consideration was canceled without the payment of consideration.
F6: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock. RSUs convert into the issuer's common stock on a one-for-one basis.
F7: The RSUs vest on the earlier of (i) the date of the issuer's next annual meeting of stockholders (or the date immediately prior to the next annual meeting of stockholders if the reporting person's service as a director ends at such meeting due to the director's failure to be re-elected or the director not standing for re-election); or (ii) the one-year anniversary measured from the date of grant. At the Effective Time, each outstanding RSU that was unvested was accelerated in full and was automatically converted in to the right to receive the Merger Consideration.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 22, 2023 Filed Feb 24, 2023 17:33 UTC | 1Life Healthcare Inc ONEM · Entity 116460 | Disposition to issuerRestricted Stock Units · Derivative | 20,728 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-23-001848 · primarydocument.xml · derivative · entry 5 Kalen Holmes · CIK 0001476414 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,728 shares Expires not disclosed F6 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock. RSUs convert into the issuer's common stock on a one-for-one basis. F7 · price: The RSUs vest on the earlier of (i) the date of the issuer's next annual meeting of stockholders (or the date immediately prior to the next annual meeting of stockholders if the reporting person's service as a director ends at such meeting due to the director's failure to be re-elected or the director not standing for re-election); or (ii) the one-year anniversary measured from the date of grant. At the Effective Time, each outstanding RSU that was unvested was accelerated in full and was automatically converted in to the right to receive the Merger Consideration. F7 · derivative.exercise_date: The RSUs vest on the earlier of (i) the date of the issuer's next annual meeting of stockholders (or the date immediately prior to the next annual meeting of stockholders if the reporting person's service as a director ends at such meeting due to the director's failure to be re-elected or the director not standing for re-election); or (ii) the one-year anniversary measured from the date of grant. At the Effective Time, each outstanding RSU that was unvested was accelerated in full and was automatically converted in to the right to receive the Merger Consideration. F7 · derivative.expiration_date: The RSUs vest on the earlier of (i) the date of the issuer's next annual meeting of stockholders (or the date immediately prior to the next annual meeting of stockholders if the reporting person's service as a director ends at such meeting due to the director's failure to be re-elected or the director not standing for re-election); or (ii) the one-year anniversary measured from the date of grant. At the Effective Time, each outstanding RSU that was unvested was accelerated in full and was automatically converted in to the right to receive the Merger Consideration. Read SEC document |
| February 22, 2023 Filed Feb 24, 2023 17:33 UTC | 1Life Healthcare Inc ONEM · Entity 116460 | Disposition to issuerStock Option (Right to Buy) · Derivative | 5,294 | Not disclosed Strike: $29.00 | Not disclosed |
DisclosureSEC source: 0001562180-23-001848 · primarydocument.xml · derivative · entry 4 Kalen Holmes · CIK 0001476414 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,294 shares Expires 2030-05-13 F5 · price: Pursuant to the Merger Agreement, at the Effective Time, each Option, whether vested or unvested, that has an exercise price per Share that is greater than the Merger Consideration was canceled without the payment of consideration. F3 · derivative.exercise_date: The shares subject to the option are fully vested and immediately exercisable. Read SEC document |
| February 22, 2023 Filed Feb 24, 2023 17:33 UTC | 1Life Healthcare Inc ONEM · Entity 116460 | Disposition to issuerStock Option (Right to Buy) · Derivative | 10,462 | Not disclosed Strike: $11.47 | Not disclosed |
DisclosureSEC source: 0001562180-23-001848 · primarydocument.xml · derivative · entry 3 Kalen Holmes · CIK 0001476414 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,462 shares Expires 2029-09-18 F2 · price: Pursuant to the Merger Agreement, at the Effective Time, each outstanding option ("Option") to purchase Shares granted under any of the Issuer's 2007 Equity Incentive Plan, 2017 Equity Incentive Plan, 2020 Equity Incentive Plan and the Iora Third Amended and Restated 2011 Equity Incentive Plan (collective, the "Issuer Stock Plans") or portion thereof that was vested or became vested as of the Effective Time, and had an exercise price per Share that is less than the Merger Consideration, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the amount by which the Merger Consideration exceeds the applicable exercise price per Share of such Option and (ii) the aggregate number of Shares issuable upon exercise of such Option or portion thereof, subject to any required withholding of taxes. F4 · derivative.exercise_date: The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the first anniversary of the vesting commencement date; and 1/48th of the shares subject to the option vest monthly thereafter over the following three years, subject to reporting person's continuous service as of each such date. At the Effective Time, any unvested shares subject to the option was accelerated in full. Read SEC document |
| February 22, 2023 Filed Feb 24, 2023 17:33 UTC | 1Life Healthcare Inc ONEM · Entity 116460 | Disposition to issuerStock Options (Right to buy) · Derivative | 13,617 | Not disclosed Strike: $11.47 | Not disclosed |
DisclosureSEC source: 0001562180-23-001848 · primarydocument.xml · derivative · entry 2 Kalen Holmes · CIK 0001476414 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,617 shares Expires 2029-09-18 F2 · price: Pursuant to the Merger Agreement, at the Effective Time, each outstanding option ("Option") to purchase Shares granted under any of the Issuer's 2007 Equity Incentive Plan, 2017 Equity Incentive Plan, 2020 Equity Incentive Plan and the Iora Third Amended and Restated 2011 Equity Incentive Plan (collective, the "Issuer Stock Plans") or portion thereof that was vested or became vested as of the Effective Time, and had an exercise price per Share that is less than the Merger Consideration, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the amount by which the Merger Consideration exceeds the applicable exercise price per Share of such Option and (ii) the aggregate number of Shares issuable upon exercise of such Option or portion thereof, subject to any required withholding of taxes. F3 · derivative.exercise_date: The shares subject to the option are fully vested and immediately exercisable. Read SEC document |
| February 22, 2023 Filed Feb 24, 2023 17:33 UTC | 1Life Healthcare Inc ONEM · Entity 116460 | Disposition to issuerCommon Stock | 4,534 | $18.00 | $81,612.00 |
DisclosureSEC source: 0001562180-23-001848 · primarydocument.xml · nonDerivative · entry 1 Kalen Holmes · CIK 0001476414 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Reflects disposition of Issuer common stock with the consummation of the transactions contemplated by the Agreement and Plan of Merger (the "Merger Agreement"), dated as of July 20, 2022, by and among Issuer, Amazon.com, Inc. ("Parent") and Negroni Merger Sub, Inc., a wholly owned subsidiary of Parent ("Merger Sub"), including the consummation of the merger (the "Merger") between Issuer and Merger Sub on February 22, 2023. Pursuant to the Merger Agreement, as of the effective time of the Merger (the "Effective Time"), each share of Issuer common stock, par value $0.001 per share ("Shares") issued and outstanding immediately prior to the Effective Time was converted automatically into the right to receive $18.00 in cash, without interest (the "Merger Consideration"). Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 20:40 UTC | 1Life Healthcare Inc ONEM · Entity 116460 | GrantRestricted Stock Units · Derivative | 20,728 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-004858 · primarydocument.xml · derivative · entry 3 Kalen Holmes · CIK 0001476414 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,728 Underlying: Common Stock · 20,728 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Restricted stock units convert into the issuer's common stock on a one-for-one basis. F2 · derivative.exercise_date: The restricted stock units vest on the earlier of (i) the date of the issuer's next annual meeting of stockholders (or the date immediately prior to the next annual meeting of stockholders if the reporting person's service as a director ends at such meeting due to the director's failure to be re-elected or the director not standing for re-election); or (ii) the one-year anniversary measured from the date of grant. F2 · derivative.expiration_date: The restricted stock units vest on the earlier of (i) the date of the issuer's next annual meeting of stockholders (or the date immediately prior to the next annual meeting of stockholders if the reporting person's service as a director ends at such meeting due to the director's failure to be re-elected or the director not standing for re-election); or (ii) the one-year anniversary measured from the date of grant. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 20:40 UTC | 1Life Healthcare Inc ONEM · Entity 116460 | Exercise / conversionRestricted Stock Units · Derivative | 4,534 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-004858 · primarydocument.xml · derivative · entry 2 Kalen Holmes · CIK 0001476414 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,534 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Restricted stock units convert into the issuer's common stock on a one-for-one basis. F2 · derivative.exercise_date: The restricted stock units vest on the earlier of (i) the date of the issuer's next annual meeting of stockholders (or the date immediately prior to the next annual meeting of stockholders if the reporting person's service as a director ends at such meeting due to the director's failure to be re-elected or the director not standing for re-election); or (ii) the one-year anniversary measured from the date of grant. F2 · derivative.expiration_date: The restricted stock units vest on the earlier of (i) the date of the issuer's next annual meeting of stockholders (or the date immediately prior to the next annual meeting of stockholders if the reporting person's service as a director ends at such meeting due to the director's failure to be re-elected or the director not standing for re-election); or (ii) the one-year anniversary measured from the date of grant. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 20:40 UTC | 1Life Healthcare Inc ONEM · Entity 116460 | Exercise / conversionCommon Stock | 4,534 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-22-004858 · primarydocument.xml · nonDerivative · entry 1 Kalen Holmes · CIK 0001476414 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,534 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Restricted stock units convert into the issuer's common stock on a one-for-one basis. Read SEC document |
| May 19, 2022 Filed May 23, 2022 22:00 UTC | RED ROBIN GOURMET BURGERS INC RRGB · Entity 6468 | GrantCommon Stock | 9,632 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-005527 · form4-05232022_060527.xml · nonDerivative · entry 1 Kalen Holmes · CIK 0001476414 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,675 F1 · shares: Represents a grant of restricted stock units under the issuer's 2017 Performance Incentive Plan, as amended. Each restricted stock unit represents the contingent right to receive, upon vesting of the unit, one share of the issuer's common stock. The units are scheduled to vest on the earlier of the first anniversary of the date of grant or the next annual meeting of stockholders. F2 · balance_after: Includes 9,632 shares subject to vesting and forfeiture restrictions. Read SEC document |
| February 16, 2022 Filed Feb 17, 2022 15:20 UTC | Zumiez Inc ZUMZ · Entity 5948 | SaleCommon Stock | 2,000 | $45.79 | $91,580.00 |
DisclosureSEC source: 0001562180-22-001561 · primarydocument.xml · nonDerivative · entry 1 Kalen Holmes · CIK 0001476414 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,087 F1 · shares: The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan previously adopted by the reporting person in December 2021. F2 · price: Shares sold at a weighted average price. Read SEC document |
| January 11, 2022 Filed Jan 11, 2022 18:59 UTC | Zumiez Inc ZUMZ · Entity 5948 | SaleCommon Stock | 2,000 | $44.87 | $89,740.00 |
DisclosureSEC source: 0001562180-22-000419 · primarydocument.xml · nonDerivative · entry 2 Kalen Holmes · CIK 0001476414 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,087 F1 · shares: The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan previously adopted by the reporting person in December 2021. F2 · price: Shares sold at a weighted average price. Read SEC document |
| November 19, 2021 Filed Jan 11, 2022 18:59 UTC | Zumiez Inc ZUMZ · Entity 5948 | GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-000419 · primarydocument.xml · nonDerivative · entry 1 Kalen Holmes · CIK 0001476414 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,087 Read SEC document |
| August 16, 2021 Filed Aug 17, 2021 17:21 UTC | Zumiez Inc ZUMZ · Entity 5948 | SaleCommon Stock | 2,483 | $41.99 | $104,261.17 |
DisclosureSEC source: 0001562180-21-005364 · primarydocument.xml · nonDerivative · entry 1 Kalen Holmes · CIK 0001476414 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,087 F1 · shares: The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan previously adopted by the reporting person in March 2021. F2 · price: Shares sold at a weighted average price. Read SEC document |
| July 15, 2021 Filed Jul 16, 2021 14:19 UTC | Zumiez Inc ZUMZ · Entity 5948 | SaleCommon Stock | 2,484 | $44.19 | $109,767.96 |
DisclosureSEC source: 0001562180-21-004964 · primarydocument.xml · nonDerivative · entry 1 Kalen Holmes · CIK 0001476414 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,570 F1 · shares: The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan previously adopted by the reporting person in March 2021. F2 · price: Shares sold at a weighted average price. Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 16:01 UTC | Zumiez Inc ZUMZ · Entity 5948 | SaleCommon Stock | 2,484 | $45.16 | $112,177.44 |
DisclosureSEC source: 0001562180-21-004292 · primarydocument.xml · nonDerivative · entry 1 Kalen Holmes · CIK 0001476414 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,054 F1 · shares: The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan previously adopted by the reporting person in March 2021. F2 · price: Shares sold at a weighted average price. Read SEC document |
| June 03, 2021 Filed Jun 7, 2021 20:26 UTC | 1Life Healthcare Inc ONEM · Entity 116460 | GrantRestricted Stock Units · Derivative | 4,534 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-004108 · primarydocument.xml · derivative · entry 1 Kalen Holmes · CIK 0001476414 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,534 Underlying: Common Stock · 4,534 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units will vest on the earlier of (i) the date of the issuer's next annual meeting of stockholders (or the date immediately prior to the next annual meeting of stockholders if the reporting person's service as a director ends at such meeting due to the director's failure to be re-elected or the director not standing for re-election); or (ii) the one-year anniversary measured from the date of grant. F2 · derivative.expiration_date: The restricted stock units will vest on the earlier of (i) the date of the issuer's next annual meeting of stockholders (or the date immediately prior to the next annual meeting of stockholders if the reporting person's service as a director ends at such meeting due to the director's failure to be re-elected or the director not standing for re-election); or (ii) the one-year anniversary measured from the date of grant. Read SEC document |
| June 02, 2021 Filed Jun 3, 2021 14:11 UTC | Zumiez Inc ZUMZ · Entity 5948 | GrantCommon Stock | 2,018 | $44.59 | $89,982.62 |
DisclosureSEC source: 0001562180-21-003982 · primarydocument.xml · nonDerivative · entry 1 Kalen Holmes · CIK 0001476414 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,538 F1 · shares: The vesting commencement date shall be the date of the next annual meeting of shareholders, which is generally scheduled to take place approximately one year from the Grant Date, in the event the Grantee does not have a Separation from Service prior to this vesting date. Read SEC document |
| May 20, 2021 Filed May 21, 2021 20:59 UTC | RED ROBIN GOURMET BURGERS INC RRGB · Entity 6468 | GrantCommon Stock | 3,201 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-005724 · edgar.xml · nonDerivative · entry 1 Kalen Holmes · CIK 0001476414 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,043 F1 · shares: Represents a grant of restricted stock units under the issuer's 2017 Performance Incentive Plan, as amended. Each restricted stock unit represents the contingent right to receive, upon vesting of the unit, one share of the issuer's common stock. The units are scheduled to vest on the earlier of the first anniversary of the date of grant or the next annual meeting of stockholders. F2 · balance_after: Includes 3,201 restricted stock units subject to vesting and forfeiture restrictions. Read SEC document |
| January 12, 2021 Filed Jan 14, 2021 20:14 UTC | 1Life Healthcare Inc ONEM · Entity 116460 | SaleCommon Stock | 100 | $42.39 | $4,239.00 |
DisclosureSEC source: 0001562180-21-000347 · primarydocument.xml · nonDerivative · entry 3 Kalen Holmes · CIK 0001476414 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| January 12, 2021 Filed Jan 14, 2021 20:14 UTC | 1Life Healthcare Inc ONEM · Entity 116460 | SaleCommon Stock | 5,101 | $41.08 | $209,565.91 |
DisclosureSEC source: 0001562180-21-000347 · primarydocument.xml · nonDerivative · entry 2 Kalen Holmes · CIK 0001476414 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100 F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan. F3 · price: This transaction was executed in multiple trades at prices ranging from $41.00 to $41.79. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 12, 2021 Filed Jan 14, 2021 20:14 UTC | 1Life Healthcare Inc ONEM · Entity 116460 | SaleCommon Stock | 26,714 | $40.20 | $1,073,902.80 |
DisclosureSEC source: 0001562180-21-000347 · primarydocument.xml · nonDerivative · entry 1 Kalen Holmes · CIK 0001476414 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,201 F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $40.00 to $40.98 The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 03, 2020 Filed Jun 4, 2020 14:45 UTC | Zumiez Inc ZUMZ · Entity 5948 | GrantCommon Stock | 3,069 | $27.69 | $84,980.61 |
DisclosureSEC source: 0001562180-20-004276 · primarydocument.xml · nonDerivative · entry 1 Kalen Holmes · CIK 0001476414 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,520 F1 · shares: The vesting commencement date shall be the date of the next annual meeting of shareholders, which is generally scheduled to take place approximately 1 year from the Grant Date in the event the Grantee does not have a Separation from Service prior to this vesting date. Read SEC document |
| May 21, 2020 Filed May 22, 2020 20:53 UTC | RED ROBIN GOURMET BURGERS INC RRGB · Entity 6468 | GrantCommon Stock | 7,768 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-006495 · edgar.xml · nonDerivative · entry 1 Kalen Holmes · CIK 0001476414 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,842 F1 · shares: Represents a grant of restricted stock units under the issuer's 2017 Performance Incentive Plan, as amended. Each restricted stock unit represents the contingent right to receive, upon vesting of the unit, one share of the issuer's common stock. The units are scheduled to vest on the earlier of the first anniversary of the date of grant or the next annual meeting of stockholders. The closing price on the date of grant was $14.16. F2 · balance_after: Includes 7,768 restricted stock units subject to vesting and forfeiture restrictions. Read SEC document |
| May 14, 2020 Filed May 18, 2020 17:47 UTC | 1Life Healthcare Inc ONEM · Entity 116460 | GrantStock Option (Right to Buy) · Derivative | 5,294 | $0.00 Strike: $29.00 | $0.00 |
DisclosureSEC source: 0001209191-20-030191 · doc4.xml · derivative · entry 1 Kalen Holmes · CIK 0001476414 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,294 Underlying: Common Stock · 5,294 shares Expires 2030-05-13 F1 · derivative.exercise_date: The shares subject to the option will vest on the earlier of (i) the date of the Issuer's next annual meeting of stockholders (or the date immediately prior to the next annual meeting of stockholders if the Reporting Person's service as a director ends at such meeting due to the director's failure to be re-elected or the director not standing for re-election); or (ii) the one-year anniversary measured from the date of grant. Read SEC document |
| December 09, 2019 Filed Dec 9, 2019 16:26 UTC | Zumiez Inc ZUMZ · Entity 5948 | SaleCommon Stock | 11,395 | $34.69 | $395,292.55 |
DisclosureSEC source: 0001562180-19-005944 · primarydocument.xml · nonDerivative · entry 1 Kalen Holmes · CIK 0001476414 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,451 Read SEC document |
| June 05, 2019 Filed Jun 6, 2019 15:11 UTC | Zumiez Inc ZUMZ · Entity 5948 | GrantCommon Stock | 4,262 | $19.94 | $84,984.28 |
DisclosureSEC source: 0001179110-19-007272 · edgar.xml · nonDerivative · entry 1 Kalen Holmes · CIK 0001476414 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,846 F1 · shares: The shares acquired represent a grant of restricted stock that will vest on June 5, 2020. Read SEC document |
| May 30, 2019 Filed Jun 3, 2019 21:52 UTC | RED ROBIN GOURMET BURGERS INC RRGB · Entity 6468 | GrantCommon Stock | 3,562 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-007047 · edgar.xml · nonDerivative · entry 1 Kalen Holmes · CIK 0001476414 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,074 F1 · shares: Represents a grant of restricted stock units under the issuer's 2017 Performance Incentive Plan. Each restricted stock unit represents the contingent right to receive, upon vesting of the unit, one share of the issuer's common stock. The units are scheduled to vest on the earlier of the first anniversary of the date of grant or the next annual meeting of stockholders. The closing price on the date of grant was $30.88 F2 · balance_after: Includes 3,562 restricted stock units subject to vesting and forfeiture restrictions. Read SEC document |
| June 06, 2018 Filed Jun 7, 2018 16:43 UTC | Zumiez Inc ZUMZ · Entity 5948 | GrantCommon Stock | 3,189 | $26.65 | $84,986.85 |
DisclosureSEC source: 0001179110-18-008216 · edgar.xml · nonDerivative · entry 1 Kalen Holmes · CIK 0001476414 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,584 F1 · shares: The shares acquired represent a grant of restricted stock that will vest on June 6, 2019. Read SEC document |
| May 30, 2018 Filed Jun 1, 2018 20:09 UTC | RED ROBIN GOURMET BURGERS INC RRGB · Entity 6468 | GrantCommon Stock | 2,184 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-007792 · edgar.xml · nonDerivative · entry 1 Kalen Holmes · CIK 0001476414 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,512 F1 · shares: Represents a grant of restricted stock units under the issuer's 2017 Performance Incentive Plan. Each restricted stock unit represents the contingent right to receive, upon vesting of the unit, one share of the issuer's common stock. The units are scheduled to vest on the earlier of the first anniversary of the date of grant or the next annual meeting of stockholders. The closing price on the date of grant was $50.35. F2 · balance_after: Includes 2,184 restricted stock units subject to vesting and forfeiture restrictions. Read SEC document |
| May 31, 2017 Filed Jun 1, 2017 15:07 UTC | Zumiez Inc ZUMZ · Entity 5948 | GrantCommon Stock | 5,986 | $14.25 | $85,300.50 |
DisclosureSEC source: 0001179110-17-008303 · edgar.xml · nonDerivative · entry 1 Kalen Holmes · CIK 0001476414 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,395 F1 · shares: The shares acquired represent a grant of restricted stock that will vest on May 31, 2018. Read SEC document |
| May 18, 2017 Filed May 22, 2017 21:54 UTC | RED ROBIN GOURMET BURGERS INC RRGB · Entity 6468 | GrantCommon Stock | 1,547 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-007766 · edgar.xml · nonDerivative · entry 1 Kalen Holmes · CIK 0001476414 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,328 F1 · shares: Represents a grant of restricted stock units under the issuer's 2017 Performance Incentive Plan. Each restricted stock unit represents the contingent right to receive, upon vesting of the unit, one share of the issuer's common stock. The units are scheduled to vest on the earlier of the first anniversary of the date of grant or the next annual meeting of stockholders. The closing price on the date of grant was $71.10. F2 · balance_after: Includes 1,547 restricted stock units subject to vesting and forfeiture restrictions. Read SEC document |
| December 15, 2010 Filed Dec 17, 2010 18:31 UTC | STARBUCKS CORP SBUX · Entity 2886 | Tax withholdingCommon Stock | 2,182 | $31.87 | $69,540.34 |
DisclosureSEC source: 0001127602-10-031182 · form4.xml · nonDerivative · entry 1 Kalen Holmes · CIK 0001476414 · evp, Partner Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,814 F1 · shares: Shares withheld by the issuer to satisfy tax withholding obligations upon vesting of restricted stock units; not an open market transaction. Read SEC document |
| November 15, 2010 Filed Nov 17, 2010 19:09 UTC | STARBUCKS CORP SBUX · Entity 2886 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 48,725 | $0.00 Strike: $30.79 | $0.00 |
DisclosureSEC source: 0001127602-10-028241 · form4.xml · derivative · entry 1 Kalen Holmes · CIK 0001476414 · evp, Partner Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,725 Underlying: Common Stock · 48,725 shares Expires 2020-11-15 F1 · derivative.exercise_date: The options become exercisable in one increment of 12,182 shares on November 15, 2011 and three increments of 12,181 shares each on November 15, 2012, November 15, 2013 and November 15, 2014. Read SEC document |
| December 15, 2009 Filed Dec 17, 2009 17:46 UTC | STARBUCKS CORP SBUX · Entity 2886 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 130,378 | $0.00 Strike: $22.73 | $0.00 |
DisclosureSEC source: 0001127602-09-025583 · form4.xml · derivative · entry 2 Kalen Holmes · CIK 0001476414 · evp, Partner Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,378 Underlying: Common Stock · 130,378 shares Expires 2019-12-15 F2 · derivative.exercise_date: Options become exercisable in two increments of 32,595 shares each on December 15, 2010 and December 15, 2011, and two increments of 32,594 shares each on December 15, 2012 and December 15, 2013. Read SEC document |
| December 15, 2009 Filed Dec 17, 2009 17:46 UTC | STARBUCKS CORP SBUX · Entity 2886 | GrantCommon Stock | 32,996 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-09-025583 · form4.xml · nonDerivative · entry 1 Kalen Holmes · CIK 0001476414 · evp, Partner Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,996 F1 · shares: Represents 32,996 Restricted Stock Units granted December 15, 2009 and vest over a four-year period, with 8,249 shares vesting on each of December 15, 2010, December 15, 2011, December 15, 2012 and December 15, 2013. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.